US Senate steps on gas in drive to abolish ACA

12 January 2017
ussenate-big

Even before the new US President has been inaugurated, the health care provision introduced to ensure affordable health care for millions of poorer Americans – and heavily criticized by Donald Trump during his election campaign – appears to be on its way out.

It follows a vote late on Wednesday which saw 51 Senators to 48 voting to pass a budget which instructs committees to write measures ending large parts of the Affordable Care Act (ACA). This health insurance scheme is often called ‘Obamacare,’ having been one of the pillars of Barack Obama’s domestic policy.

Protests by Democratic Senators at the potential impact on as many as 20 million Americans who have been insured by the ACA were ignored as the budget was approved, an action which, the New York Times explains, sets the stage for a reconciliation bill that can then be used to repeal significant parts of the health law and, critically, is immune from being blocked.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical